Akston Biosciences

About:

Akston Biosciences Corporation leverages its novel fusion protein platform to develop and manufacture new classes of biologics.

Website: https://www.akstonbio.com

Top Investors: EQx Fund, Cherrystone Angel Group, National Institute of Diabetes and Digestive and Kidney Diseases, Angel Healthcare Investors

Description:

Akston Biosciences Corporation leverages its novel fusion protein platform to develop and manufacture new classes of biologics, including vaccines, ultra-long-acting insulins, and autoimmune disease therapies. It was founded in 2011 and headquartered in Beverly, Massachusetts.

Total Funding Amount:

$46.6M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Beverly, Massachusetts, United States

Founded Date:

2011-01-01

Contact Email:

info(AT)akstonbio.com

Founders:

Todd C. Zion

Number of Employees:

51-100

Last Funding Date:

2022-04-14

IPO Status:

Private

Industries:

© 2025 bioDAO.ai